It was observed that anti-PGRN antibodies can induce ovarian cancer cell apoptosis through the regulation of cleaved caspase-3 (CASP3), nuclear condensation, DNA fragmentation and poly (ADP-ribose) polymerase (PARP) cleavage [83]. This evidence concerns the gene CASP3 and ovarian carcinoma.